Healthy joint function is linked to overall quality of life, and work productivity. Joint inflammation, pain, stiffness and immobility can have destructive effects on physical performance, and the quality of everyday life. According to a recent report released by the World Health Organization, musculoskeletal disorders are the most frequent cause of disability in the modern world, and the prevalence of these diseases is rising at an alarming rate.64 Acute damage caused by an injury, gradual deterioration, or damage due to repetitive, excessive joint loading with consequent joint abnormalities, causes lifelong pain and disability for many millions of people. 1
So don’t forget to protect your joints from daily wear and tear. Let’s see how to head off problems and heal the aches you may already have.
GLUCOSAMINE & CHONDROITIN
Glucosamine, and chondroitin sulfate, as important basic natural components of cartilage and synovial fluid, have been used for medicinal purposes for nearly 40 years.
Supplementation of such basic components has been thought to exert beneficial effects, especially when there is an imbalance between catabolic and anabolic processes, such as in degenerative joint diseases. 2 Studies have indicated that glucosamine and chondroitin may exert a positive effect on pain relief, function improvement, and joint space narrowing in patients with joint problems and diseases. 6-13
In fact, the European League Against Rheumatism (EULAR) rated glucosamine and chondroitin with the highest level of evidence, and with the highest recommendation strength, in their evidence-based approach to the management of knee osteoarthritis. 2, 3
OMEGA 3
Omega-3 fatty acids are involved in inflammatory responses. Their metabolites inhibit the production of inflammatory signaling molecules responsible for arthritic pain. This is why they been used to relieve joint pain and inflammation associated with joint diseases, such as rheumatoid arthritis, osteoarthritis. 22-37
In an extensive analysis, researchers from the University of Toronto concluded that Omega-3 supplementation reduces patient reported joint pain, minutes of morning stiffness, number of painful and/or tender joints, and the necessary amount of NSAID (nonsteroidal anti-inflammatory drug) usage. 22
In addition, it has also been shown that the co-supplementation of omega-3 fatty acids and glucosamine in patients with existing joint diseases achieved better improvements in symptoms than glucosamine alone. 22, 23
MSM
MSM (Methylsulfonylmethane) is a non-pharmacologic nutrition supplement used against osteoarthritis. MSM is a complex containing organic sulfur, that is used by the body to maintain and repair connective tissue.38 Some evidence from clinical and non-clinical trials suggest that it may exhibit some anti-inflammatory, antioxidant, anti-atherosclerotic and chemo-preventive properties. 38, 39, 40, 41
In clinical trials, where subjects with existing joint problems, arthritic and rheumatic pain were supplemented with 3 to 6 grams of MSM daily, an improvement in pain and physical function was observed.38, 43, 44, 45
In addition, the combination of glucosamine and chondroitin with MSM showed clinical benefit for patients with existing joint disease, compared with only glucosamine and chondroitin or placebo.46
VITAMIN C & ROSE HIPS
Arthralgia (pain in a joint) is a symptom of the vitamin C deficiency disease scurvy. Vitamin C not only contributes to normal collagen formation that forms connective fibers in tissues such as ligaments, cartilage, and bones, but contributes to the protection of cells from oxidative stress. It has also been found to exert a pain-relieving effect.47, 48
In a study from Denmark, patients with existing hip or knee joint diseases showed reduced pain following vitamin C supplementation (in the form of calcium ascorbate) for 2 weeks. 47, 48
When choosing a vitamin C supplement, be sure that it contains added rosehips. Rosehip extract contains polyphenols and anthocyanins, which are believed to ease joint inflammation and prevent joint damage. Studies have found that rosehips can reduce the production of specific enzymes that break down cartilage, and cause cell injury in several joint disease such as osteoarthritis.49-56
UC-II
Collagen is the main structural protein in various connective tissues in animal bodies, in fact it is the most abundant protein in the human body. Collagen has numerous types. So far, 28 types of collagen have been identified, but about 90% of the collagen in the body consist of type I, II, and III. Of these, type II is the main collagenous component of cartilage.
UC-II is a natural ingredient which contains a patented form of undenatured type II collagen derived from chicken sternum. Clinical studies support the safety and efficacy of UC-II in modulating joint discomfort in patient with existing joint diseases (osteoarthritis and rheumatoid arthritis). 57-63
In addition, a study published in the Journal of the International Society of Sports Nutrition showed that daily supplementation with 40 mg of UC-II improved joint function and joint pain due to strenuous exercise in healthy subjects.57
References ▼
- Buckwalter JA, Anderson DD, Brown TD, Tochigi Y, Martin JA. The Roles of Mechanical Stresses in the Pathogenesis of Osteoarthritis: Implications for Treatment of Joint Injuries. Cartilage. 2013;4(4):286-294. doi:10.1177/1947603513495889.
- Jerosch J. Effects of Glucosamine and Chondroitin Sulfate on Cartilage Metabolism in OA: Outlook on Other Nutrient Partners Especially Omega-3 Fatty Acids. International Journal of Rheumatology. 2011;2011:969012. doi:10.1155/2011/969012.
- Jordan KM, Arden NK, Doherty M, et al. EULAR Recommendations 2003: an evidence based approach to the management of knee osteoarthritis: report of a task force of the standing committee for international clinical studies including therapeutic trials (ESCISIT) Annals of the Rheumatic Diseases. 2003;62(12):1145–1155.
- Bruyère O, Altman RD, Reginster JY: Efficacy and safety of glucosamine sulfate in the management of osteoarthritis: Evidence from real-life setting trials and surveys. Semin Arthritis Rheum. 2016 Feb;45(4 Suppl):S12-7. doi: 10.1016/j.semarthrit.2015.11.011. Epub 2015 Dec 2.
- Bruyère O, Cooper C, Pelletier JP, Maheu E, Rannou F, Branco J, Luisa Brandi M, Kanis JA, Altman RD, Hochberg MC, Martel-Pelletier J, Reginster JY.: A consensus statement on the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) algorithm for the management of knee osteoarthritis-From evidence-based medicine to the real-life setting. Semin Arthritis Rheum. 2016 Feb;45(4 Suppl):S3-11. doi: 10.1016/j.semarthrit.2015.11.010. Epub 2015 Dec 2.
- McAlindon TE., LaValley MP, Gulin JP, Felson DT.: Glucosamine and chondroitin for treatment of osteoarthritis: a systematic quality assessment and meta-analysis. JAMA. 2000 Mar 15;283(11):1469-75.
- Towheed TE., Maxwell L, Anastassiades TP, Shea B, Houpt J, Robinson V, Hochberg MC, Wells G.: Glucosamine therapy for treating osteoarthritis. Cochrane Database Syst Rev. 2005 Apr 18;(2):CD002946.
- Black C., Clar C, Henderson R, MacEachern C, McNamee P, Quayyum Z, Royle P, Thomas S.: The clinical effectiveness of glucosamine and chondroitin supplements in slowing or arresting progression of osteoarthritis of the knee: a systematic review and economic evaluation. Health Technol Assess. 2009 Nov;13(52):1-148. doi: 10.3310/hta13520.
- Richy F, Bruyere O, Ethgen O, Cucherat M, Henrotin Y, Reginster JY.: Structural and symptomatic efficacy of glucosamine and chondroitin in knee osteoarthritis: a comprehensive meta-analysis. Arch Intern Med. 2003 Jul 14;163(13):1514-22.
- Lee YH., Woo JH, Choi SJ, Ji JD, Song GG.: Effect of glucosamine or chondroitin sulfate on the osteoarthritis progression: a meta-analysis. Rheumatol Int. 2010 Jan;30(3):357-63. doi: 10.1007/s00296-009-0969-5. Epub 2009 Jun 21.
- Singh JA, Noorbaloochi S, MacDonald R, Maxwell LJ. Chondroitin for osteoarthritis. The Cochrane database of systematic reviews. 2015;1:CD005614. doi:10.1002/14651858.CD005614.pub2.
- Zeng C, Wei J, Li H, et al. Effectiveness and safety of Glucosamine, chondroitin, the two in combination, or celecoxib in the treatment of osteoarthritis of the knee. Scientific Reports. 2015;5:16827. doi:10.1038/srep16827.
- Hochberg MC, Martel-Pelletier J, Monfort J, Möller I, Castillo JR, Arden N, Berenbaum F, Blanco FJ, Conaghan PG, Doménech G, Henrotin Y, Pap T, Richette P, Sawitzke A, du Souich P, Pelletier JP, MOVES Investigation Group.: Combined chondroitin sulfate and glucosamine for painful knee osteoarthritis: a multicentre, randomised, double-blind, non-inferiority trial versus celecoxib. Ann Rheum Dis. 2016 Jan; 75(1):37-44.
- Müller-Fassbender H, Bach GL, Haase W, Rovati LC, Setnikar I.: Glucosamine sulfate compared to ibuprofen in osteoarthritis of the knee. Osteoarthritis Cartilage. 1994 Mar;2(1):61-9.
- Qiu GX, Gao SN, Giacovelli G, Rovati L, Setnikar I.: Efficacy and safety of glucosamine sulfate versus ibuprofen in patients with knee osteoarthritis. Arzneimittelforschung. 1998 May;48(5):469-74.
- Lopes Vaz A.: Double-blind clinical evaluation of the relative efficacy of ibuprofen and glucosamine sulphate in the management of osteoarthrosis of the knee in out-patients. Curr Med Res Opin. 1982;8(3):145-9.
- Rovati LC.: Clinical research in osteoarthritis: design and results of short-term and long-term trials with disease-modifying drugs. Int J Tissue React. 1992;14(5):243-51.
- Wang Y, Prentice LF, Vitetta L, Wluka AE, Cicuttini FM.: The effect of nutritional supplements on osteoarthritis. Altern Med Rev. 2004 Sep;9(3):275-96.
- Zhang W Moskowitz RW, Nuki G, Abramson S, Altman RD, Arden N, Bierma-Zeinstra S, Brandt KD, Croft P, Doherty M, Dougados M, Hochberg M, Hunter DJ, Kwoh K, Lohmander LS, Tugwell P.: OARSI recommendations for the management of hip and knee osteoarthritis, Part II: OARSI evidence-based, expert consensus guidelines. Osteoarthritis Cartilage. 2008 Feb;16(2):137-62. doi: 10.1016/j.joca.2007.12.013.
- Vasiliadis HS, Tsikopoulos K. Glucosamine and chondroitin for the treatment of osteoarthritis. World Journal of Orthopedics. 2017;8(1):1-11. doi:10.5312/wjo.v8.i1.1.
- Bruyere O, Burlet N, Delmas PD, et al. Evaluation of symptomatic slow-acting drugs in osteoarthritis using the GRADE system. BMC Musculoskeletal Disorders. 2008;9, article 165
- Goldberg RJ, Katz J.: A meta-analysis of the analgesic effects of omega-3 polyunsaturated fatty acid supplementation for inflammatory joint pain. Pain. 2007 May;129(1-2):210-23. Epub 2007 Mar 1.
- Gruenwald J, Petzold E, Busch R, Petzold HP, Graubaum HJ.: Effect of glucosamine sulfate with or without omega-3 fatty acids in patients with osteoarthritis. Adv Ther. 2009 Sep;26(9):858-71. doi: 10.1007/s12325-009-0060-3. Epub 2009 Sep 4.
- Ariza-Ariza R, Mestanza-Peralta M, Cardiel HH.: Omega-3 fatty acids in rheumatoid arthritis: an overview. 1998 Semin. Arthritis Rheum. 27, 366-370.
- Fortin PR, Lew RA, Liang MH, Wright EA, Beckett LA, Chalmers TC, Sperling RI: Validation of a meta-analysis: the effects of fish oil in rheumatoid arthritis. 1995 J. Clin. Epidemiol. 48, 1379-1390.
- Adam O, Beringer C, Kless T, Lemmen C , Adam A, Wiseman M, Adam P, Klimmek R, Forth W.: Anti-inflammatory effects of a low arachidonic acid diet and fish oil in patients with rheumatoid arthritis. 2003Rheumatol. Int. 23, 27-36.
- Belch J Ansell D, Madhok R, O‟Dowd A, Sturrock R.: Effects of altering dietary essential fatty acids on requirements for non-steroidal anti-inflammatory drugs in patients with rheumatoid arthritis: A double-blind, placebo-controlled study. 1988 Annals of Rheumatic Diseases 47, 96-104.
- Berbert AA, Kondo CR, Almendra CL, Matsuo T, Dichi I.: Supplementation of fish oil and olive oil in patients with rheumatoid arthritis. 2005 Nutrition 21, 131-136.
- Calder PC.: The scientific basis for fish oil supplementation in rheumatoid arthritis. In: Food and Nutritional Supplements – Their role in health and disease. 2000 Ransley JK, Donnelly JK, Read NW, (Eds). Springer, Berlin, 75-197.
- Curtis CL, Rees SG, Cramp J, Flannery CR, Hughes CE, Little CB, Williams R, Wilson C, Dent CM, Harwood JL, Caterson B.: Notice of retraction. Effects of n-3 fatty acids on cartilage metabolism.2006 Proc. Nutr. Soc. 65, 434.
- Kremer JM, Jubiz W, Michalek A, Rynes RI, Bartholomew LE, Bigaouette J, Timchalk M, Beeler D, Lininger L.: Fish-oil fatty acid supplementation in active rheumatoid arthritis. A double- blinded, controlled, crossover study. 1987 Ann. Intern. Med. 106, 497-503.
- Kremer JM.: n-3 fatty acid supplements in rheumatoid arthritis, 2000 Am. J. Clin. Nutr. 71 (suppl), 349S-51S.
- Nielsen GL, Faarvang KL, Thomsen BS, Teglbjaerg KL, Jensen LT, Hansen TM, Lervang HH, Schmidt EB, Dyerberg J, Ernst E.: The effects of dietary supplementation with n-3 polyunsaturated fatty acids in patients with rheumatoid arthritis: a randomised, double-blind trial. 1992 Eur. J. Clin. Invest. 22, 687-691.
- Ramsbottom H, Lockwood B.: Nutraceuticals for healthy joints, 2006 The Pharmaceutical Journal 277, 740-746.
- James MJ, Cleland LG.: Dietary n-3 fatty acids and therapy for rheumatoid arthritis. Semin Arthritis Rheum. 1997 Oct;27(2):85-97.
- James MJ, Cleland LG.: Dietary n-3 fatty acids and therapy for rheumatoid arthritis. Semin Arthritis Rheum. 1997 Oct;27(2):85-97.
- Cleland LG, James MJ.: Osteoarthritis. Omega-3 fatty acids and synovitis in osteoarthritic knees. Nat Rev Rheumatol. 2012 Apr 17;8(6):314-5. doi: 10.1038/nrrheum.2012.60.
- A., Givissis P.A., Kritis A.C., Christodoulou A.C. The effect of methylsulfonylmethane on osteoarthritic large joints and mobility. Int. J. Orthop. 2014;1:19–24.
- Ebisuzaki K. Aspirin and methylsulfonylmethane (MSM): a search for common mechanisms, with implications for cancer prevention. Anticancer Res 2003; 23: 453-458
- Alam SS, Layman DL. Dimethyl sulfoxide inhibition of prostacyclin production in cultured aortic endothelial cells. Ann N Y Acad Sci 1983; 411: 318-320
- Beilke MA, Collins-Lech C, Sohnle PG. Effects of dimethyl sulfoxide on the oxidative function of human neutrophils. J Lab Clin Med 1987; 110: 91-96
- Butawan M, Benjamin RL, Bloomer RJ. Methylsulfonylmethane: Applications and Safety of a Novel Dietary Supplement. Nutrients. 2017;9(3):290. doi:10.3390/nu9030290.
- Kim LS, Axelrod LJ, Howard P, Buratovich N, Waters RF.: Efficacy of methylsulfonylmethane (MSM) in osteoarthritis pain of the knee: a pilot clinical trial. Osteoarthritis Cartilage. 2006 Mar;14(3):286-94. Epub 2005 Nov 23.
- Debbi EM, Agar G, Fichman G, et al. Efficacy of methylsulfonylmethane supplementation on osteoarthritis of the knee: a randomized controlled study. BMC Complementary and Alternative Medicine. 2011;11:50. doi:10.1186/1472-6882-11-50.
- Debi R., Fichman G., Ziv Y.B., Kardosh R., Debbi E., Halperin N., Agar G. The role of msm in knee osteoarthritis: A double blind, randomized, prospective study. Osteoarthr. Cartil. 2007;15:C231. doi: 10.1016/S1063-4584(07)62057-3.
- Lubis AMT, Siagian C, Wonggokusuma E, Marsetyo AF, Setyohadi B.: Comparison of Glucosamine-Chondroitin Sulfate with and without Methylsulfonylmethane in Grade I-II Knee Osteoarthritis: A Double Blind Randomized Controlled Trial. Acta Med Indones. 2017 Apr;49(2):105-111.
- Carr AC, McCall C. The role of vitamin C in the treatment of pain: new insights. Journal of Translational Medicine. 2017;15:77. doi:10.1186/s12967-017-1179-7.
- Jensen NH. Reduced pain from osteoarthritis in hip joint or knee joint during treatment with calcium ascorbate. A randomized, placebo-controlled cross-over trial in general practice. Ugeskr Laeger. 2003;165(25):2563–2566
- Warholm O, Skaar S, Hedman E, Mølmen HM, Eik L. The Effects of a Standardized Herbal Remedy Made from a Subtype of Rosa canina in Patients with Osteoarthritis: A Double-Blind, Randomized, Placebo-Controlled Clinical Trial. Current Therapeutic Research, Clinical and Experimental. 2003;64(1):21-31. doi:10.1016/S0011-393X(03)00004-3.
- Winther K, Apel K, Thamsborg G.: A powder made from seeds and shells of a rose-hip subspecies (Rosa canina) reduces symptoms of knee and hip osteoarthritis: a randomized, double-blind, placebo-controlled clinical trial. Scand J Rheumatol. 2005 Jul-Aug;34(4):302-8.
- Rein E, Kharazmi A, Winther K.: A herbal remedy, Hyben Vital (stand. powder of a subspecies of Rosa canina fruits), reduces pain and improves general wellbeing in patients with osteoarthritis–a double-blind, placebo-controlled, randomised trial. Phytomedicine. 2004 Jul;11(5):383-91.
- Rossnagel K, Roll S, Willich SN. [The clinical effectiveness of rosehip powder in participants with osteoarthritis. A systematic review.] MMW – Fortschritte der Medizin 2007; 149(11):51–56. [Article in German].
- Chrubasik C, Duke RK, Chrubasik S. The evidence for clinical efficacy of rose hip and seed: a systematic review. Phytotherapy Research 2006; 20(1):1–3.
- Rein E, Kharazmi A, Winther K. A herbal remedy, Hyben Vital (stand. Powder of a subspecies of Rosa canina fruits), reduces pain and improves general wellbeing in participants with osteoarthritis – a double-blind, placebo-controlled, randomised trial. Phytomedicine 2004; 11(5):383–91.
- Warholm O, Skaar S, Hedman E, Molmen HM, Eik L. The effects of a standardized herbal remedy made from a subtype of Rosa canina in participants with osteoarthritis: a double-blind, randomised, placebo-controlled clinical trial. Current Therapeutic Research 2003; 64:21–31.
- Willich SN, Rossangel K, Roll S, Wagner A, Mune O, Erlendson J, Kharazmi A, Sörensen H, Winther K. Rose hip herbal remedy in participants with rheumatoid arthritis – a randomised controlled trial. Phytomedicine 2010; 17:87–93.
- Lugo JP, Saiyed ZM, Lau FC, et al. Undenatured type II collagen (UC-II®) for joint support: a randomized, double-blind, placebo-controlled study in healthy volunteers. Journal of the International Society of Sports Nutrition. 2013;10:48. doi:10.1186/1550-2783-10-48.
- Crowley DC, Lau FC, Sharma P, et al. Safety and efficacy of undenatured type II collagen in the treatment of osteoarthritis of the knee: a clinical trial. International Journal of Medical Sciences. 2009;6(6):312-321.
- Lugo JP, Saiyed ZM, Lau FC, et al. Undenatured type II collagen (UC-II®) for joint support: a randomized, double-blind, placebo-controlled study in healthy volunteers. Journal of the International Society of Sports Nutrition. 2013;10:48. doi:10.1186/1550-2783-10-48.
- Barnett ML, Kremer JM, St Clair EW, Clegg DO, Furst D, Weisman M, Fletcher MJ, Chasan-Taber S, Finger E, Morales A, Le CH, Trentham DE. Treatment of rheumatoid arthritis with oral type II collagen. Results of a multicenter, double-blind, placebo-controlled trial. Arthritis Rheum. 1998;41(2):290–7. [PubMed]
- Barnett ML, Combitchi D, Trentham DE. A pilot trial of oral type II collagen in the treatment of juvenile rheumatoid arthritis. Arthritis Rheum. 1996;39(4):623–8. [PubMed]
- Trentham DE. Evidence that type II collagen feeding can induce a durable therapeutic response in some patients with rheumatoid arthritis. Ann N Y Acad Sci. 1996;778:306–14. [PubMed]
- Trentham DE, Dynesius-Trentham RA, Orav EJ, Combitchi D, Lorenzo C, Sewell KL, Hafler DA, Weiner HL. Effects of oral administration of type II collagen on rheumatoid arthritis. Science. 1993;261(5129):1727–30. [PubMed]
- McDougall JJ. Arthritis and Pain. Neurogenic origin of joint pain. Arthritis Research & Therapy. 2006;8(6):220. doi:10.1186/ar2069.